EAN 2024 | Options for treating rare and complex epilepsies

Reetta Kälviäinen, MD, PhD, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland, discusses emerging treatment options for rare and complex epilepsies. She highlights neurostimulation as a key focus, emphasizing its growing applications for treating these conditions. While resective epilepsy surgery remains the primary treatment for focal epilepsies, neurostimulation serves as an alternative when surgery is not viable. Prof. Kälviäinen also mentions advancements in genetic diagnostics and gene therapy, noting that while gene therapy shows promise, more research is needed to assess its effectiveness and cost-efficiency for patients. This interview took place at the European Academy of Neurology (EAN) Annual Meeting 2024 in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.